Baird Medical Investment Holdings Limited (BDMD)
Healthcare
- Fundamental
- 1
- Sentiment
- 2
- Technical
- 1
Do Nothing: fundamentalScore 1 and qualitativeScore 2 are both below the required floor of 3 (hard block; shadow branch unavailable with the rendered flag false), and the chart is additionally unsupportable for a long — max overnight gap 31.57% (> 5%) and recent 3-session dollar volume ~$1.41M (< $1.5M).
Company overview
Baird Medical Investment Holdings Limited, based in Guangzhou, China, specializes in the development and commercialization of microwave ablation medical devices. These devices are used in minimally invasive treatments for various tumors, including thyroid, liver, lung, and breast cancers.
Fundamental
very weakBaird Medical shows operational improvement but faces significant capital structure and delisting risks.
Speculative micro-cap: the first-half 2026 operating turnaround is real (revenue +24.6%, positive GAAP operating income, +$2.46M operating cash flow), but the equity is boxed in by a $4.35M senior secured variable-conversion convertible, only $0.29M of cash, receivables that turn over in roughly 457 days, and an active Nasdaq minimum-bid deficiency against a $3.6M market cap. Too risky for a short-horizon position.
Sentiment
weakMedia sentiment has deteriorated due to delisting risks, despite some positive operational developments.
Dominant near-term driver is the 2026-11-04 Nasdaq minimum-bid-price deficiency notice (announced), which pulled media polarity to -0.05 in the 14-day scoring window from +0.21 in the 30-90-day baseline - a determinate deterioration - against a real but unrewarded bullish offset in the 2026-11-02 exclusive 19-market China distribution agreement (initial $900k order) and the 2026-11-05 partner FDA 510(k)/CE submissions. A moderate red-flag cap applied for conflicting catalyst signals while the severe screen stayed clean (no regulator-confirmed investigation, no going-concern or auditor modification, no trial verdict or refinancing wall inside 30 days), and retail sentiment is indeterminate because Reddit access was blocked.
Technical
very weakThe stock is in a strong downtrend, trading below all major moving averages with only oversold indicators suggesting a potential bounce.
Chart quality 1/5: price below all moving averages within a vertical multi-month decline (3.43 on 2026-03-06 → 0.1095 on 2026-11-11), ADX14 51.18 confirming very strong trend strength in the DOWN direction, MACD -0.17/-0.17/0.00 negative and flat, and only deeply oversold RSI14 23.08 / Williams %R -90.81 as a bullish counterweight; ATR14 0.08 is ~71% of company.price, so risk distances and ATR-scaled targets are not practically tradable. Independent of the chart, the trade is barred: fundamentalScore 1 and qualitativeScore 2 are both below the required floor of 3 (hard block; shadow flag rendered false), the max overnight gap is 31.57% (> 5%), and the recent 3-session regular-session dollar volume of ~$1.41M is below the $1.5M recent-liquidity floor. technicalScore reflects the broken chart only; Do Nothing.
You’re looking at 2026-11-11 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.

